John Hayslip
Chief Tech/Sci/R&D Officer bei VERASTEM, INC.
Profil
John Hayslip is currently the Chief Medical Officer at Verastem, Inc. He previously worked as the Director-Clinical Research & Data Management at The Markey Cancer Center Foundation and as the Vice President-Clinical Development at Nektar Therapeutics.
From 2022 to 2024, he served as the Chief Medical Officer at I-Mab.
Dr. Hayslip holds a graduate degree from the Medical University of South Carolina and a doctorate degree from Northeast Ohio Medical University.
Aktive Positionen von John Hayslip
| Unternehmen | Position | Beginn |
|---|---|---|
| VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 18.04.2024 |
Ehemalige bekannte Positionen von John Hayslip
| Unternehmen | Position | Ende |
|---|---|---|
| I-MAB | Chief Tech/Sci/R&D Officer | 15.04.2024 |
| The Markey Cancer Center Foundation | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | - |
Ausbildung von John Hayslip
| Medical University of South Carolina | Graduate Degree |
| Northeast Ohio Medical University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| VERASTEM, INC. | Health Technology |
| I-MAB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
| The Markey Cancer Center Foundation |
